Predicting Phospholipidosis: A Fluorescence Noncell Based in Vitro Assay for the Determination of Drug–Phospholipid Complex Formation in Early Drug Discovery

2011 ◽  
Vol 83 (18) ◽  
pp. 6980-6987 ◽  
Author(s):  
Liping Zhou ◽  
Gina Geraci ◽  
Sloan Hess ◽  
Linhong Yang ◽  
Jianling Wang ◽  
...  
2020 ◽  
Vol 386 ◽  
pp. 114831 ◽  
Author(s):  
Darja Gramec Skledar ◽  
Václav Tvrdý ◽  
Maša Kenda ◽  
Anamarija Zega ◽  
Milan Pour ◽  
...  

2006 ◽  
Vol 13 (1) ◽  
pp. 19-25 ◽  
Author(s):  
Erik L. Munson ◽  
Dean T. Nardelli ◽  
K. H. Kevin Luk ◽  
Monica C. Remington ◽  
Steven M. Callister ◽  
...  

ABSTRACT Determination of the immunological mediators responsible for promoting the production of borreliacidal antibody may facilitate the development of an improved borreliosis vaccine for human and veterinary use. Previously, we developed an in vitro assay to determine if borreliacidal antibody production could be augmented by treatment with different cytokines. In this study, in vitro treatment of lymph node cells producing borreliacidal antibody with recombinant interleukin-6 (rIL-6) resulted in a fourfold enhancement of anti-OspA borreliacidal antibody. Moreover, rIL-6 enhanced Western immunoblot titers and increased the number of B lymphocytes. In contrast, treatment of anti-OspA borreliacidal antibody-producing cells with anti-IL-6 resulted in a fourfold reduction in borreliacidal activity. Treatment with anti-IL-6 also inhibited enhanced borreliacidal antibody production induced by anti-gamma interferon. These data suggest that IL-6 plays a significant role in the production of anti-OspA borreliacidal antibodies.


2004 ◽  
Vol 325 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Abhai K Tripathi ◽  
Shabana I Khan ◽  
Larry A Walker ◽  
Babu L Tekwani

Sign in / Sign up

Export Citation Format

Share Document